January 1996
Vol 14 Issue 1 MaLAM complains to the International Federation of Pharmaceutical Manufacturers Associations about Parke-Davis' promotion of Ponstan (mefenemic acid) for fever in children in Pakistan.
Our members can see and make comments on this page.
Please
Register
(read more)
then
Log in
for free access to more features of this website.
Don't know your username or password?
Please log in to access sharing tools.
There are 34 days until the
Selling Sickness conference
Seminário folheto: Épossível fazer melhor! (We can do better!), Porto,Portugal Oct 11
Conference Update: Quality information for quality use of medicines, Kazan, Russia, 15-16 Oct, 2010
Healthy Skepticism announcements now on Twitter
Endorsements for Selling Sickness conference
Book: Misinformed Consent - Women’s Stories About Unnecessary Hysterectomy
Next issue: Servier Arcalion (sulbutiamine) and Duxaril (almitrine/raubasine)
Previous issue: SmithKline Beecham Halfan (halofantrine)
